Core Viewpoint - Hanma Technology Group Co., Ltd. announced the resignation of Mr. Fan Ruirui from the position of Executive Vice President due to personal reasons, effective immediately upon submission of his resignation report to the board [2]. Group 1: Resignation Details - Mr. Fan Ruirui submitted his resignation report on August 5, 2025, and will no longer hold any position within the company after resigning as Executive Vice President [2]. - The resignation is in accordance with the Company Law of the People's Republic of China and the company's articles of association, and it has been processed without any impact on the company's normal operations [2]. Group 2: Company Response - The company and its board expressed gratitude for Mr. Fan Ruirui's contributions during his tenure [2].

关于公司高级管理人员离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 汉马科技集团股份有限公司（以下简称"本公司"或"公司"）董事会于 2025 年 8 月 5 日收到范瑞瑞先生的书面辞职报告，范瑞瑞先生因个人原因申请辞去公 司常务副总经理职务。辞去公司常务副总经理职务后范瑞瑞先生不再担任公司任 何职务。 一、董事/高级管理人员离任情况 (一) 提前离任的基本情况 汉马科技集团股份有限公司 证券代码：600375 证券简称：汉马科技 公告编号：临 2025-050 汉马科技集团股份有限公司 经理 5日 11 日 (二) 离任对公司的影响 根据《中华人民共和国公司法》及《公司章程》的规定，范瑞瑞先生上述辞 职事项自书面辞职报告送达董事会之日起生效，公司已做好相关工作安排，范瑞 瑞先生离任不会影响公司的正常生产经营。 本公司及董事会对范瑞瑞先生在任职期间为公司发展所做出的贡献表示衷 心的感谢。 特此公告。 汉马科技集团股份有限公司 汉马科技集团股份有限公司董事会 | | | | 是否继续在上 | 是否存在 ...

Group 1 - The core viewpoint of the news is that Hanma Technology (600375) has shown significant growth in its latest financial performance, with a notable increase in revenue and net profit [1] - As of August 5, 2025, Hanma Technology's stock closed at 6.93 yuan, with a trading volume of 40.58 million shares and a transaction amount of 283 million yuan [1] - The company's total revenue for the first quarter of 2025 was 1.32 billion yuan, representing a year-on-year growth of 43.93%, while the net profit attributable to shareholders was 11.76 million yuan, up 117.90% year-on-year [1] Group 2 - Hanma Technology has made investments in 7 companies and participated in 58 bidding projects, indicating active engagement in business expansion [2] - The company holds 17 trademark registrations and 213 patents, showcasing its commitment to innovation and intellectual property [2] - Hanma Technology has 16 administrative licenses, reflecting its compliance with regulatory requirements [2]

（文章来源：每日经济新闻） 汉马科技（SH 600375，收盘价：6.93元）8月5日晚间发布公告称，汉马科技集团股份有限公司董事会 于2025年8月5日收到范瑞瑞先生的书面辞职报告，范瑞瑞先生因个人原因申请辞去公司常务副总经理职 务。辞去公司常务副总经理职务后范瑞瑞先生不再担任公司任何职务。 2024年1至12月份，汉马科技的营业收入构成为：汽车制造业占比96.03%，其他业务占比3.67%，融资 租赁占比0.3%。 ...

汉马科技集团股份有限公司 证券代码：600375 证券简称：汉马科技 公告编号：临 2025-050 汉马科技集团股份有限公司 关于公司高级管理人员离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 1 汉马科技集团股份有限公司 重要内容提示： 汉马科技集团股份有限公司（以下简称"本公司"或"公司"）董事会于 2025 年 8 月 5 日收到范瑞瑞先生的书面辞职报告，范瑞瑞先生因个人原因申请辞去公 司常务副总经理职务。辞去公司常务副总经理职务后范瑞瑞先生不再担任公司任 何职务。 一、董事/高级管理人员离任情况 | 姓名 | 离任职务 | | | 离任时间 | | | 原定任期到 | 离任原因 | 是否继续在上 市公司及其控 | 是否存在未 履行完毕的 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | 期日 | | 股子公司任职 | 公开承诺 | | 范瑞瑞 | 常 副 | 务 | 总 | 2025 ...

人民财讯8月5日电，汉马科技（600375）8月5日晚间公告，范瑞瑞因个人原因申请辞去公司常务副总经 理职务。辞去公司常务副总经理职务后范瑞瑞不再担任公司任何职务。 ...

Group 1 - The commercial vehicle sector increased by 0.37% on August 5, with Shuguang Co. leading the gains [1] - The Shanghai Composite Index closed at 3617.6, up 0.96%, while the Shenzhen Component Index closed at 11106.96, up 0.59% [1] - Key stocks in the commercial vehicle sector showed varied performance, with Shuguang Co. closing at 3.72, up 2.76% [1] Group 2 - The commercial vehicle sector experienced a net outflow of 4.92 billion yuan from institutional investors, while retail investors saw a net inflow of 3.58 billion yuan [2] - Among individual stocks, China National Heavy Duty Truck had a net inflow of 972.34 million yuan from institutional investors, but a net outflow of 1499.16 million yuan from retail investors [3] - Foton Motor and Shuguang Co. also showed mixed fund flows, with Foton Motor seeing a net inflow of 731.12 million yuan from institutional investors [3]

Core Viewpoint - Hanma Technology Group Co., Ltd. reported strong production and sales performance in July 2025, particularly in the electric medium and heavy-duty truck segment, indicating robust growth momentum [2]. Production Summary - The production of trucks (including incomplete vehicles) reached 909 units in July, a 40.49% increase from 647 units in the same month last year. Cumulative production for the year stands at 7,019 units, up 55.84% from 4,504 units year-on-year [3][5]. - Electric medium and heavy-duty trucks were a highlight, with July production of 777 units, a significant increase of 219.75% from 243 units last year. Year-to-date production is 5,271 units, up 136.79% from 2,226 units [3][5]. - However, the chassis assembly production was poor, with zero units produced in July, down 100% from 212 units last year. Year-to-date production is 232 units, down 84.14% from 1,463 units [3][5]. - The production of alcohol-hydrogen power systems was 202 units in July, a 69.75% increase from 119 units last year, but cumulative production for the year is 1,603 units, down 32.28% from 2,367 units [4]. Sales Summary - Truck sales (including incomplete vehicles) reached 956 units in July, a 42.69% increase from 670 units last year. Year-to-date sales are 7,181 units, up 53.64% from 4,674 units [6][7]. - Electric medium and heavy-duty truck sales also showed strong performance, with 845 units sold in July, a 160% increase from 325 units last year. Year-to-date sales are 5,279 units, up 134.73% from 2,249 units [6][7]. - Chassis assembly sales were zero in July, down 100% from 213 units last year, with cumulative sales of 232 units, down 85.84% from 1,638 units [6][7]. - Alcohol-hydrogen power system sales were 236 units in July, a decrease of 22.11% from 303 units last year, with cumulative sales of 1,934 units, down 2.18% from 1,977 units [6][7]. - Overall, the company's focus on electric medium and heavy-duty trucks and other new energy products is beginning to yield results, providing new momentum for sustainable development [7].

Core Viewpoint - Hanma Technology Group Co., Ltd. has released its production and sales data for July 2025, ensuring the accuracy and completeness of the information provided [1]. Group 1: Production and Sales Data - The company reported its production and sales figures for July 2025, with specific data to be confirmed in the regular financial reports [1].

Group 1 - Yabont Chemical signed a 10-year supply strategic agreement with Jiangsu Hengrui Medicine to enhance collaboration in the pharmaceutical supply chain, effective from August 1, 2025 [1] - Wei Hua New Materials plans to acquire controlling interest in Jiangsu Heyutai Chemical to extend its product chain and improve competitiveness, currently in the planning stage [2] - Fujirey received a government subsidy of 2.0074 million yuan, expected to positively impact profits in 2025 [4] Group 2 - Hangzhou Garden won the land use rights for a plot in Yuhang District for 130 million yuan, planning to build a smart ecological design R&D headquarters with a total investment of no more than 450 million yuan [5] - Baotai's clinical trial for BAT5906, a recombinant anti-VEGF monoclonal antibody, received approval for new indications, aiming to accelerate commercialization [6] - Weisheng Information won multiple projects with a total bid amount of 110 million yuan, including significant contracts with Southern Power Grid and State Grid [8] Group 3 - Dong'an Power reported a 27.37% year-on-year increase in engine sales for July, totaling 34,500 units [13] - Hanma Technology's truck sales reached 956 units in July, marking a 42.69% year-on-year increase [14] - Jiangsu Bank's executives received regulatory approval for their positions, effective immediately [15] Group 4 - Chip Origin expects Q2 revenue of 584 million yuan, a 49.90% increase quarter-on-quarter, with significant growth in intellectual property licensing fees [24] - Dream Network Technology plans to establish a high-end equipment industry investment fund with a target fundraising of 2 billion yuan [26] - Hefei Urban Construction and China Real Estate Development won land use rights for a residential plot in Hefei for 980 million yuan [28] Group 5 - Lu Kang Pharmaceutical's subsidiary received a drug registration certificate for a new medication for erectile dysfunction [28] - Lifan Pharmaceutical's Mesalazine enteric-coated tablets received a drug registration certificate for treating ulcerative colitis [29] - Yahu Pharmaceutical's APL-1401 clinical trial for ulcerative colitis showed positive preliminary results [30]